Same Indication

Mirvetuximab Soravtansine vs Trastuzumab

Mirvetuximab Soravtansine vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Mirvetuximab Soravtansine and Trastuzumab.

Mechanism of Action

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Trastuzumab β€” 28 days.

Chemical Properties

Type: Mirvetuximab Soravtansine β€” Antibody drug conjugate; Trastuzumab β€” Antibody.